Pharmaceutical industry

Mylan Underpaid U.S. on Rebates for EpiPen
Merck Buys Cough Drug Developer for $1.25B
Pfizer Adds Eczema Gel With $5B Anacor Deal
Biotech CFO Accused of Misleading Investors
Ireland’s Shire Buys Baxalta for $32 Billion
Valeant Stock Falls 10% on News of CEO’s Illness
Novartis Settles Kickback Charges for $370M
Shire to Buy Rival Drug Maker Dyax for $5.9B
Cipla Buys Two U.S. Pharma Firms for $550M
Teva to Buy Allergan’s Generic Drug Unit for $40.5B